0001104659-21-153333.txt : 20211223
0001104659-21-153333.hdr.sgml : 20211223
20211223214243
ACCESSION NUMBER: 0001104659-21-153333
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211222
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paykel Neela
CENTRAL INDEX KEY: 0001894593
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39949
FILM NUMBER: 211518755
MAIL ADDRESS:
STREET 1: 530 OLD WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hyperfine, Inc.
CENTRAL INDEX KEY: 0001833769
STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 NEW WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
BUSINESS PHONE: 866-796-6767
MAIL ADDRESS:
STREET 1: 351 NEW WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
FORMER COMPANY:
FORMER CONFORMED NAME: HealthCor Catalio Acquisition Corp.
DATE OF NAME CHANGE: 20201124
4
1
tm2135698-16_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-22
0
0001833769
Hyperfine, Inc.
HYPR
0001894593
Paykel Neela
C/O HYPERFINE, INC.
530 OLD WHITFIELD STREET
GUILFORD
CT
06437
0
1
0
0
Gen Counsel & Corp Secretary
Stock Option (right to buy)
3.27
2021-12-22
4
A
0
98250
A
2031-04-27
Class A Common Stock
98250
98250
D
The shares underlying this option vested as to 25% on June 30, 2022, with the remainder of the options vesting in equal monthly installments over the following three years, subject to Ms. Paykel's continued service through the applicable vesting date.
In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc.,
a Delaware corporation ("Liminal"), pursuant to which Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), the option was received in the Mergers in exchange for a stock option to acquire 300,000 shares of Hyperfine common stock for $1.07.
/s/ John P. Condon, Attorney-in-Fact
2021-12-23